Journal
ONCOLOGY REPORTS
Volume 31, Issue 4, Pages 1691-1698Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2014.3033
Keywords
hepatocellular carcinoma; Rap1; apoptosis; NF-kappa B
Categories
Funding
- Applied Basic Research Programs of Science and Technology Commission Foundation of Yunnan Province [2011FB064, 2012FB065]
Ask authors/readers for more resources
Recent studies have revealed that repressor/activator protein (Rap1) not only protects telomeres from sister chromatid exchange, but also functions in genomewide transcriptional regulation. Knockdown of Rap1 sensitizes breast cancer cells to adriamycin-induced apoptosis. However, little is known about the role of Rap1 in the progression of hepatocellular carcinoma (HCC). The present study aimed to investigate the functions of Rap1 in HCC progression and to determine whether targeting the Rap1 signaling pathway may be of therapeutic value against HCC. We found knockdown of Rap1 by microRNA (miRNA) interference enhanced significantly apoptosis and 5-fluorouracil (5-FU) chemosensitivity in HepG2 cell line. Rap1 miRNA downregulated nuclear factor-kappa B p65 (NF-kappa B p65) expression, and upregulated inhibitor of NF-kappa B (I kappa B) expression. In vivo, Rap1 miRNA combined with 5-FU treatment led to a significant reduction of tumor growth as compared with 5-FU alone. The results indicate that Rap1 miRNA can effectively enhance sensitivity of HepG2 cell line to 5-FU chemotherapy in vitro and in vivo.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available